Correlation Between Anebulo Pharmaceuticals and Personalis

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Anebulo Pharmaceuticals and Personalis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anebulo Pharmaceuticals and Personalis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Anebulo Pharmaceuticals and Personalis, you can compare the effects of market volatilities on Anebulo Pharmaceuticals and Personalis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anebulo Pharmaceuticals with a short position of Personalis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anebulo Pharmaceuticals and Personalis.

Diversification Opportunities for Anebulo Pharmaceuticals and Personalis

0.31
  Correlation Coefficient

Weak diversification

The 3 months correlation between Anebulo and Personalis is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Anebulo Pharmaceuticals and Personalis in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Personalis and Anebulo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anebulo Pharmaceuticals are associated (or correlated) with Personalis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Personalis has no effect on the direction of Anebulo Pharmaceuticals i.e., Anebulo Pharmaceuticals and Personalis go up and down completely randomly.

Pair Corralation between Anebulo Pharmaceuticals and Personalis

Given the investment horizon of 90 days Anebulo Pharmaceuticals is expected to generate 1.78 times more return on investment than Personalis. However, Anebulo Pharmaceuticals is 1.78 times more volatile than Personalis. It trades about 0.2 of its potential returns per unit of risk. Personalis is currently generating about -0.21 per unit of risk. If you would invest  125.00  in Anebulo Pharmaceuticals on October 22, 2024 and sell it today you would earn a total of  34.00  from holding Anebulo Pharmaceuticals or generate 27.2% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Anebulo Pharmaceuticals  vs.  Personalis

 Performance 
       Timeline  
Anebulo Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Anebulo Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong technical and fundamental indicators, Anebulo Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Personalis 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Personalis are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite quite uncertain basic indicators, Personalis disclosed solid returns over the last few months and may actually be approaching a breakup point.

Anebulo Pharmaceuticals and Personalis Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Anebulo Pharmaceuticals and Personalis

The main advantage of trading using opposite Anebulo Pharmaceuticals and Personalis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anebulo Pharmaceuticals position performs unexpectedly, Personalis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Personalis will offset losses from the drop in Personalis' long position.
The idea behind Anebulo Pharmaceuticals and Personalis pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Other Complementary Tools

Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences